Drug Shows Promise for Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia



Ibrutinib, a new drug under development, is showing promise as a treatment for mantle cell lymphoma and chronic lymphocytic leukemia (CLL), according to new studies.



Source link

Comments are closed.